Published in Law and Health Weekly, April 22nd, 2006
Study 1: Myocardial perfusion imaging with adenosine triphosphate (ATP) is as effective as dipyridamole for the diagnosis of coronary artery disease (CAD).
According to investigators from Japan, "Myocardial perfusion imaging with adenosine triphosphate (ATP) has been used increasingly to diagnose coronary artery disease (CAD) and assess risk for this disease. This study compared absolute myocardial blood flow (MBF) and myocardial flow reserve index (MFR) with ATP and dipyridamole (DIP) in patients with CAD."
"MBF was quantified by 15O-H2 O...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.